Current Drug Targets
Title:Meet Our Editorial Board Member
Volume: 21 Issue: 16
Author(s): L. Zhang
Affiliation:
Export Options
About this article
Cite this article as:
Zhang L. , Meet Our Editorial Board Member, Current Drug Targets 2020; 21 (16) . https://dx.doi.org/10.2174/138945012116201102140615
DOI https://dx.doi.org/10.2174/138945012116201102140615 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ximelagatran: An Oral Direct Thrombin Inhibitor for Anticoagulant Therapy
Letters in Drug Design & Discovery Salt: A Review of its Role in Food Science and Public Health
Current Nutrition & Food Science Inflammatory Responses in Brain Ischemia
Current Medicinal Chemistry Conotoxins: Structure, Therapeutic Potential and Pharmacological Applications
Current Pharmaceutical Design Clinical Trajectories and Biological Features of Primary Progressive Aphasia (PPA)
Current Alzheimer Research Meet Our Co-Editor:
Current HIV Research ACKNOWLEDGEMENT
Recent Patents on Cardiovascular Drug Discovery Pharmacological and Cellular Therapies to Prevent Restenosis after Percutaneous Transluminal Angioplasty and Stenting
Cardiovascular & Hematological Agents in Medicinal Chemistry Pro-oxidant- Antioxidant Balance (PAB) in Rheumatoid Arthritis and its Relationship to Disease Activity
Current Rheumatology Reviews Donepezil Improves Gait Performance in Patients with an Acute Cerebral Infarction: A Prospective Observational Cohort Study
Current Neurovascular Research Triglyceride Level Affecting Shared Susceptibility Genes in Metabolic Syndrome and Coronary Artery Disease
Current Medicinal Chemistry Purine Derivatives as Ligands for A3 Adenosine Receptors
Current Topics in Medicinal Chemistry Transcriptomic Effects of Estrogen Starvation and Induction in the MCF7 Cells. The Meta-analysis of Microarray Results
Current Pharmaceutical Biotechnology Intravascular Ultrasound Guided Percutaneous Coronary Intervention for Chronic Total Occlusion
Current Cardiology Reviews Pain Management in Hematological Patients with Major Organ Dysfunctions and Comorbid Illnesses
Cardiovascular & Hematological Agents in Medicinal Chemistry Perspective on ‘Phase V’ or Logistics and Regression as Logical Progression for Community Heart Failure Triage
Current Cardiology Reviews Maternal Nutrition and Predisposition to Later Kidney Disease
Current Drug Targets Meet Our Editorial Board Member
Cardiovascular & Hematological Agents in Medicinal Chemistry Pernicious Anemia: Fundamental and Practical Aspects in Diagnosis
Cardiovascular & Hematological Agents in Medicinal Chemistry COVID-19 and Diabetes: will Novel Drugs for Diabetes Help in COVID-19?
Current Molecular Pharmacology